Summary
The purpose of this study was to determine the distribution of ER+ (estrogen receptor) and PR+ (progesterone receptor) epithelial cells in normal mammary tissue or in tissue in contact with or involved in benign or malignant processes. Three important findings emerged from this study.
First, a true dissociation was observed between ER+ and PR+ cells in mammary tissue. In premenopausal women some cells express only progesterone receptors. In premenopausal normal tissue, regardless of the menstrual cycle status, 6% of cells are ER+ and 29% PR+.
Second, during the menstrual cycle the percentage of positive cells varies. This finding would indicate a change in cell recruitment rather than in intracellular levels.
Finally, specific changes in the proportion of positive cells in normal tissue in contact with epithelial proliferations were noted. This finding suggests the possibility of either a diffusible factor or a cellular pathological process spreading beyond areas displaying morphological changes.
References
Kouyoumdjian JC: Etude des récepteurs des hormones stéroides dans la glande mammaire normale et dans les mastopathies bénignes. Bull Cancer 73: 120–123, 1986
Jacquemier J, Charpin C, Martin PM: Etude immunohistochimique par anticorps monoclonal (H222 SP) des récepteurs oestrogéniques: Corrélations avec l'analyse biochimique (par radio-ligand) pour 115 carcinomes mammaires. Bull Cancer 73: 107–119, 1986
Fournier S, Prudhomme JF, Martin PM, Kuttenn F: Récepteurs des hormones stéroides dans les mastopathies bénignes. Path Biol 31: 767–773, 1983
Silva JS, Georgiade GS, Dilley WG, Mc Carty KS, Wells SA, Mc Carty KS: Menstrual cycle-dependent variations of breast cyst fluid proteins and sex steroid receptors in the normal human breast. Cancer 51: 1297–1302, 1983
Jacquemier J, Gandilhon PH, Charpin C, Pourreau-Schneider N, Hassoun J, Martin PM: Tissu mammaire: récepteurs estrogéniques. Analyse immunohistochimique et biochimique du tissu normal, hyperplasique et du carcinome in situ. A propos de 86 cas. Bull Cancer 74: 129–149, 1987
Perrot-Applanat M, Groyer-Picard MT, Lorenzo, Jolivet A, Thu Vu Hai M, Pallud C, Spyratos F, Milgrom E: Immunocytochemical study with monoclonal antibodies to progesterone receptor in human breast tumors. Cancer Res 47: 2652–2661, 1987
Clark GM, McGuire WL: Prognostic factors in primary breast cancer. Breast Cancer Res Treat 3: 69–72, 1983
McGuire WL: Prognostic factors for recurrence and survival in human breast cancer. Breast Cancer Res Treat 10: 5–9, 1987
Kuttenn F, Fournier S, Durand JC, Mauvais-Jarvis P: Estradiol and progesterone receptors in human breast fibroadenomas. J Clin Endocrinol Metab 52: 1225, 1981
Clark JH, Hsueh AJW, Peck EJ: Regulation of estrogen receptor replienishment by progesterone. Ann NY Acad Sci 286: 161–179, 1977
Horwitz KB, McGuire WL, Pearson OH: Predicting response to endocrine therapy in human breast cancer: A hypothesis. Science 189: 726–727, 1975
Magdelenat H, Pertuiset BF, Poisson M: Progestin and oestrogen receptors in meningiomas. Biochemical characterization, clinical and pathological correlations in 42 cases. Acta Neurochir 64: 199–213, 1982
Tilzer LL, Plapp FC, Evans JP, Stone D, Alward K: Steroid receptor proteins in human meningiomas. Cancer 49: 633–636, 1982
Poisson M: Sex steroid receptors in human meningiomas. Clin Neuropharmacol 7: 320–324, 1984
Horwitz KB, Mockus MB, Lessey BA: Variant T47D human breast cancer cells with high progesterone receptor levels despite estrogen and antiestrogen resistance. Cell 28: 633–642, 1982
Hissom JR, Moore MR: Progestin effects on growth in the human breast cancer cell line T47D Possible therapeutic implications. Biochem Biophys Res Commun 145: 706–711, 1987
Kiang DT, Kollander R: Breast cancers negative for estrogen receptor but positive for progesterone receptor. A true entity? J Clin Oncol 5: 662–666, 1987
King RJB: An overview of the steroid receptor machinery. In: Nunez J, Dumont JE, King RJB (eds) Hormones and Cell Regulation. (Colloque INSERM 139). John Libbey, London, 1986, pp 55–67
Sheridan PJ, Buchanen JM, Anselmo VC, Martin PM: Equilibrium: The intracellular distribution of steroid receptors. Nature 282: 579–582, 1979
Sheridan PJ, Martin PM, Blum K: Steroid hormone dynamics: A function of cellular equilibrium. In: Sheridan PJ, Blum K, Trachtenberg MC (eds) Steroid Receptors and Disease: Cancer Autoimmune, Bone, and Circulatory Disorders. M. Dekker, New York, 1988, pp 49–70
Jacquemier J, Rolland PH, Vague D, Lieutaud R, Spitalier JM, Martin PM: Relationships between steroid receptor and epithelial cell proliferation in benign fibrocystic disease of the breast. Cancer 49: 2534–2536, 1982
Giani C, D'Amore E, Delarue JC, Mouriesse H, May-Levin F, Sancho-Garnier H, Breccia M, Contesso G: Estrogen and progesterone receptors in benign breast tumors and lesions: relationship with histological and cytological features. Int J Cancer 37: 7–10, 1986
Hawkins RA, Tesdale AL, Ferguson WA, Going JJ: Oestrogen receptor activity an intraduct and invasive breast carcinomas. Breast Cancer Res Treat 9: 129–133, 1987
Mignot L, Espie M, de Roquancourt A, Gorins A: Les récepteurs hormonaux et les lésions pré-cancéreuses du sein. Path Biol 31: 761–764, 1983
Petersen OW, Hoyer PE, Van Deurs B: Frequency and distribution of estrogen receptor-positive cells in normal, nonlacting human breast tissue. Cancer Res 47: 5748–5751, 1987
Miller WR, Hawkins RA, Forrest APM: Significance of aromatase activity in human breast cancer. Cancer Res 42: 3365–3368, 1982
O'Neill JS, Miller WR: Aromatase activity in breast adipose tissue from women with benign and malignant breast diseases. Br J Cancer 56: 601–604, 1987
Arteaga CL, Tandon AK, Von Hoff DD, Osborne CK: Transforming growth factor β: Potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res 48: 3898–3904, 1988
Fabbro D, Küng W, Roos W, Regazzi R, Eppenberger U: Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship. Cancer Res 46: 2720–2725, 1986
Nicholson S, Sainsbury JRC, Needham GK, Chambers P, Farndon JR, Harris AL: Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance. Int J Cancer 42: 36–41, 1988
Pekonen F, Partanen S, Mäkinen T, Rutanen EM: Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer. Cancer Res 48: 1343–1347, 1988
Berthois Y, Dong XF, Martin PM: Regulation of epidermal growth factor-receptor by estrogen and antiestrogen in the human breast cancer cell line MCF-7 (in press)
Lippman ME, Dickson RB, Bates S, Knabbe C, Huff K, Swain S, Mc Manawas M, Bronzert D, Kasid A, Gelmann E: Autocrine and paracrine growth regulation of human breast cancer. Breast Cancer Res Treat 7: 59–70, 1986
Wilding G, Lippman ME, Dickson RB: The cellular response of human breast cancer to estrogen. In: Hankins WD, Buett D (eds) Progress in clinical and biological research. Alan R. Liss, New York, 1988, 262, pp 181–196
Wellings SR, Jensen HM: On the origin and progression of ductal carcinoma in the human breast. J Nat Cancer Inst 50 1111–1115, 1973
Rudland PS: Stem cells and the development of mammary cancers in experimental rats and in humans. Cancer Metast Rev 6: 55–83, 1987
Russo J, Russo I: Biology of disease. Biological and molecular bases of mammary carcinogenesis. Lab Invest 57: 112–137, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jacquemier, J.D., Hassoun, J., Torrente, M. et al. Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages — Immunohistochemical study of 107 cases. Breast Cancer Res Tr 15, 109–117 (1990). https://doi.org/10.1007/BF01810783
Issue Date:
DOI: https://doi.org/10.1007/BF01810783